Related Experiment Video
Updated: Sep 19, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Valuation of the Alzheimer's Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in
Daniel A Araya-Ríos1, Kim-Huong Nguyen2, Tracy A Comans3
1School of Medicine, Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
Objectives:
To estimate utility weights for the Alzheimer's Disease 5 Dimensions (AD-5D) instrument in the Chilean population to obtain health utilities.
Methods:
A panel sample of the Chilean population was recruited online to complete a discrete choice experiment with time duration. Weights were built based on region of residence, gender, age, and educational level. The experimental design comprised 20 blocks, each composed of 12 choice sets. In each choice set, participants compared 2 health states described by the 5 AD-5D dimensions and the life duration. A multinomial logit model was used to analyze the data, and preference parameters were anchored to the health utility scale to produce utility weights that can be used to estimate quality-adjusted life years.
Results:
The study included 1895 participants who completed the discrete choice tasks. The weighted sample showed that the respondents were more educated than the general population of Chile. However, other characteristics were comparable. The Physical Health dimension had the greatest impact on utility, followed by Living Situation, Mood, Memory, and Ability to do things for fun. The health utility values ranged from 1 to -1.09, with 23% of health states having negative utilities.
Conclusions:
To our knowledge, this study provides the first AD-5D utility weights for the Chilean population to be used in trials, healthcare, and economic evaluations of dementia-related interventions. Because the AD-5D instrument is based on the Quality of Life Alzheimer's Disease Instrument, the estimated health utility weights allow estimation of quality-adjusted life years whenever the Quality of Life Alzheimer's Disease is available.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....